The Patent Finder

Terms ending in 2028

Pfizer Inc.

Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,877,761Novel N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole Derivatives as PKC Kinase Inhibitors
Grace period ended Nov 4, 2026 · lapse expected
 · Low confidence
Pfizer Inc.Grace period ended Nov 4, 2026
lapse expected
Low confidence
US 9,518,060SUBSTITUTED PYRROLO[3,4-c]PYRAZOLES AS PKC KINASE INHIBITORS
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
US 10,316,045SUBSTITUTED PYRROLO[3,4-c]PYRAZOLES AS PKC KINASE INHIBITORS
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
US 11,220,518SUBSTITUTED N-PYRIMIDIN-4-YL-3-Amino-PYRROLO[3,4-c]PYRAZOLES AS PROTEIN KINASE C INHIBITORS
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
US 11,780,853SUBSTITUTED N-PYRIMIDIN-4-YL-3-Aminopyrrolo[3,4-c]PYRAZOLES AS PROTEIN KINASE C INHIBITORS
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
US 8,721,601Dose Setting Mechanism for an Injection Device
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 7,632,854Aminoindazole Derivatives Active as Kinase Inhibitors, Process for Their Preparation and Pharmaceutical Compositions Comprising Them
In force
 · High confidence
Nerviano Medical Sciences S.R.LIn forceHigh confidence
US 8,247,411Sulfonyl Amide Derivatives for the Treatment of Abnormal Cell Growth
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 8,440,822Sulfonyl Amide Derivatives for the Treatment of Abnormal Cell Growth
In force
 · Medium confidence
Pfizer, Inc.In forceMedium confidence
US 10,450,297Sulfonyl Amide Derivatives for the Treatment of Abnormal Cell Growth
In force
 · Low confidence
Pfizer, Inc.In forceLow confidence
8 more term ends in 2028 · Pro
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18, including 10 expiring within the 18 months from Nov 16, 2026.
Upgrade to Pro
10 of these are in force and held by Pfizer Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited